Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
Pilot study evaluates sensitive skin burden in persons of color
- Author:
- Doug Brunk
“We were particularly surprised by the high rates of reactivity to skin care products designed for and marketed to those suffering with sensitive...
News
Expert shares her tips for diagnosing, treating onychomycosis
- Author:
- Doug Brunk
“We need to be antifungal stewards, because resistant dermatophytes are coming,” Dr. Boni E. Elewski said.
News
Phase 3 prurigo nodularis trial shows positive results for nemolizumab
- Author:
- Doug Brunk
“The use of topical steroids was not allowed in this trial,” Dr. Shawn G. Kwatra said.
News
Novel single-use patch shows promise for primary axillary hyperhidrosis
- Author:
- Doug Brunk
“This is a new kind of device that is going to be a nice tool to have.”
News
CSU in children: Study identifies biomarkers associated with responses to different treatments
- Author:
- Doug Brunk
“Our study furthers our current understanding of the role of different biomarkers in treatment response.”
News
Study finds quality of topical steroid withdrawal videos on YouTube subpar
- Author:
- Doug Brunk
“We were disheartened that patient testimonial videos had the poorest quality and reliability of the information sources,” Erika McCormick said....
News
Spironolactone: an ‘inexpensive, effective’ option for acne in women
- Author:
- Doug Brunk
“Spironolactone is fairly accessible, inexpensive, and effective for our patients,” Dr. Julie C. Harper said.
News
Spinosad: New kid on the block for treating scabies
- Author:
- Doug Brunk
The formulation “drives the active compound to the stratum corneum, where mites live and breed,” Dr. Anthony J. Mancini said.
News
Racial morphing: A conundrum in cosmetic dermatology
- Author:
- Doug Brunk
“I have patients coming in who want to look like the social media photos they’ve curated, maybe larger lips or more definition in their jawline,”...
News
Be vigilant about suspected cases of measles, expert advises
- Author:
- Doug Brunk
“This is a re-emerging viral infection that dermatologists must recognize,” Dr. Adelaide A. Hebert said.
News
Skin reactions from melanoma targeted and immune therapies range from pruritus to SJS
- Author:
- Doug Brunk
Appearance of vitiligo is regarded as a good prognostic factor in the treatment of melanoma with various checkpoint inhibitors alone or in...
News
Expert dispels myths about hair care in patients with skin of color
- Author:
- Doug Brunk
“You want to perform the scalp and hair exam with cultural humility,” Dr. Candrice R. Health said.
News
Topical or intralesional cidofovir an option for recalcitrant warts
- Author:
- Doug Brunk
Some studies have suggested that one in three children in primary school suffers from warts.
News
Treating nail psoriasis: Intralesional injections and biologics
- Author:
- Doug Brunk
When Dr. Armstrong performs intramatricial injections, she uses triamcinolone acetonide at 10 mg/mL.
News
Treating rosacea: Combination therapy, benzoyl peroxide, and the ‘STOP’ mnemonic
- Author:
- Doug Brunk
“We’ve been more comfortable with the idea of combination therapy for acne than we have been for rosacea,” Dr. Julie C. Harper said.